Neurona Therapeutics

Neurona Therapeutics is driven by rigorous scientific discovery and focused on developing breakthrough treatments for neurological disorders. Neurona Therapeutics is a privately-held, clinical-stage biotherapeutics company focused on discovering and developing allogeneic neural cell therapies to treat chronic diseases of the nervous system. Neurona was founded by leading-edge neuroscientists and stem cell pioneers at the University of California, San Francisco. Based on nearly two decades of research, we believe that specific neural cell lineages have the unique ability to integrate and repair dysregulated neural circuits. We have built a robust regenerative medicine discovery platform and developed proprietary methods to manufacture specific types of fully-differentiated neuronal, glial, and gene-edited cell therapy candidates for targeted delivery into the damaged nervous system. Product manufacturing is performed in Neurona’s cGMP facility.